The minimally important difference of the Asthma Control Test

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 4, 2009, Pages

  Schatz, Michael ^a   Kosinski, Mark ^b   Yarlas, Aaron S ^b   Hanlon, Jennifer ^b   Watson, Maria E ^c   Jhingran, Priti ^c  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b QualityMetric   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

anchor based method; Asthma; asthma control; Asthma Control Test; distribution based method; minimally important difference

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SHORT ACTING DRUG;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; ASTHMA; ASTHMA CONTROL; ASTHMA CONTROL TEST; CONTROLLED STUDY; CRITERION VARIABLE; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTION TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SPIROMETRY; TREATMENT DURATION; VALIDATION STUDY; IMMUNOLOGY; MIDDLE AGED; QUESTIONNAIRE;

ADRENERGIC BETA-AGONISTS; ADULT; ASTHMA; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 70449713433     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.06.053     Document Type: Article

References (23)

1. Asthma Prevalence, Health Care Use, and Mortality: US, 2003-2005. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/ashtma03-05/asthma03-05.htm. Accessed August 26, 2008.
2. National Asthma Education and Prevention Program. Expert panel report 3: guidelines for the diagnosis and management of asthma. J Allergy Clin Immunol 120 suppl (2007) S93-S138
3. Global strategy for asthma management and prevention, Global Initiative for Asthma (GINA) 2007. Available at: http://www.ginasthma.org. Accessed August 26, 2008.
4. Nathan R.A., Sorkness C.A., Kosinski M., Schatz M., Li J.T., Marcus P., et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 113 (2004) 59-65
5. Vollmer W.M., Markson L.E., O'Connor E., Frazier E.A., Berger M., and Buist A.S. Association of asthma control with healthcare utilization. A prospective evaluation. Am J Respir Crit Care Med 165 (2002) 195-199
6. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.G., and King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999) 902-907
7. Schatz M., Sorkness C.A., Li J.T., Marcus P., Murray J.J., Nathan R.A., et al. Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol 117 (2006) 549-556
8. Schatz M., Mosen D.M., Kosinski M., Vollmer W.M., Magid D.J., O'Connor E., et al. Validity of the Asthma Control Test completed at home. Am J Manag Care 13 (2007) 661-667
9. Schatz M., Zeiger R., Drane A., Harden K., Cibildak A., Oosterman J., et al. Reliability and predictive validity of the Asthma Control Test administered by telephone calls using speech recognition technology. J Allergy Clin Immunol 119 (2007) 336-343
10. Jaeschke R., Singer J., and Guyatt G.H. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 10 (1989) 407-415
11. Guyatt G.H., Osoba D., Wu A., Wyrwich K.W., and Norman G.R. Methods to explain the clinical significance of health status measures. Mayo Clin Proc 77 (2002) 371-383
12. Revicki D., Hays R.D., Cella D., and Sloan J. Recommended methods for determining responsiveness and minimally important differences for patient reported outcomes. J Clin Epidemiol 61 (2008) 102-109
13. Hays R.D., Farivar S.S., and Liu H. Approaches and recommendations for estimating minimally important differences for health-related quality of life measures. COPD 2 (2005) 63-67
14. Yost K.J., and Eton D.T. Combining distribution- and anchor-based approaches to determine minimally important differences. Eval Health Prof 28 (2005) 172-191
15. Kosinski M., Kite A., Yang M., Carranza Rosenzweig J., and Williams A. Comparability of the Asthma Control Test telephone interview format with self-administered mail-out mail-back format. Curr Med Res Opin 25 (2009) 717-727
16. Norman G.R., Sloan J.A., and Wyrwich K.W. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 41 (2003) 582-592
17. Wyrwich K.W., Tierney W.M., and Wolinsky F.D. Further evidence supporting a SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life instruments. J Clin Epidemiol 52 (1999) 861-873
18. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. (1988), Lawrence Erlbaum Associates, Hillsdale (NJ)
19. Jacobson N.S., and Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol 59 (1991) 12-19
20. Wyrwich K.W., and Wolinsky F.D. Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Pract 6 (2000) 39-49
21. Hedges L.V. Distribution theory for Glass's estimator of effect size and related estimators. J Ed Stat 6 (1981) 107-128
22. Schatz M., Zeiger R.S., Vollmer W.M., Mosen D., Apter A.J., Stibolt T.B., et al. Validation of a β-agonist long-term asthma control scale derived from computerized pharmacy data. J Allergy Clin Immunol 117 (2006) 995-1000
23. Juniper E.F., Svensson K., Mörk A.C., and Ståhl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 99 (2005) 553-558